October 15th, 2021
Harvard University and Resilience announce five-year R&D alliance to incubate new technologies, launch companies to advance the manufacture of complex medicines
First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders